The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4904-4913

  Krajcsi, Peter ^a,b   Dimitrov, Todor ^a   Hermiston, Terry W ^a   Tollefson, Ann E ^a   Ranheim, Todd S ^a   Vande Pol, Scott B ^c   Stephenson, Alan H ^a   Wold, William S M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; TUMOR NECROSIS FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CYTOLYSIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030015292     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4904-4913.1996     Document Type: Article

References (91)

1. Ames, R. S., B. Holskin, M. Mitcho, D. Shalloway, and M. J. Chen. 1990. Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J. Virol. 64:4115-4122.
2. Baumann, H., and J. Gauldie. 1994. The acute phase response, Immunol. Today 15:74-80.
3. Beetens, J. R., W. Loots, Y. Somers, M. C. Coene, and Y. De Clerck. 1986. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem. Pharmacol. 35:883-891.
4. 2. J. Biol. Chem. 260:6899-6906.
5. Brady, H. A., A. Scaria, and W. S. M. Wold. 1992. Map of cis-acting sequences that determine alternative pre-mRNA processing in the E3 complex transcription unit of adenovirus. J. Virol. 66:5914-5923.
6. Brady, H. A., and W. S. M. Wold. 1987. Identification of a novel sequence that governs both polyadenylation and alternative splicing in region E3 of adenovirus. Nucleic Acids Res. 15:9397-9416.
7. Chang, D. J., G. M. Ringold, and R. A. Heller. 1992. Cell killing and induction of manganous Superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem. Biophy. Res. Commun. 188:538-546.
8. Chen, M. J., B. Holskin, J. Strickler, J. Gorniak, M. A. Clark, P. J. Johnson, M. Mitcho, and D. Shalloway. 1987. Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature (London) 330:581-583.
9. Chiou, S. K., C. C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553-6566.
10. 2+ -dependent translocation domain with homology to PKC and GAP. Cell 65:1043-1051.
11. Decker, T., and M.-L. Lohmann-Matthes. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods 15:61-69.
12. 2,. J. Biol. Chem. 269:13057-13060.
13. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193-4200.
14. Duerksen-Hughes, P. J., T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1991. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J. Virol. 65:1236-1244.
15. 2 translocates to membrane fraction in human neutrophils activated by Stimuli that phosphorylate mitogen-activated protein kinase. Proc. Natl. Acad. Sci. USA 91:3142-3146.
16. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. A. Prince. 1989. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86:3823-3827.
17. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
18. Gooding, L. R. 1994. Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect. Agents Dis. 3:106-115.
19. Gooding, L. R., L. Aquino, P. J, Duerksen-Hughes, D. Day, T. M. Horton, S. P. Yei, and W. S. M. Wold. 1991. The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J. Virol. 65:3083-3094.
20. Gooding, L. R., L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. M. Wold. 1988. A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53:341-346.
21. Gooding, L. R., T. S. Ranheim, A. E. Tollefson, L. Aquino, P. Duerksen-Hughes, T. M. Horton, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65:4114-4123.
22. Gooding, L. R., I. O. Sofola, A. E. Tollefson, P. Duerksen-Hughes, and W. S. M. Wold. 1990. The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis. J. Immunol. 145:3080-3086.
23. Gooding, L. R., and W. S. M. Wold. 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit. Rev. Immunol. 10:53-71.
24. Green, M., and W. S. M. Wold. 1979. Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol. 58:425-435.
25. Haliday, E. M., C. S. Ramesha, and G. Ringold. 1991. TNF induces c-fos via a novel pathway requiring conversion of arachidonic acid to a lipoxygenase metabolite. EMBO J. 10:109-115.
26. Hannun, Y. A. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269:3125-3128.
27. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
28. 2 is crucial in the cytoloxic action of tumor necrosis factor. J. Biol. Chem. 268:11290-11295.
29. Heller, R. A., and M. Krönke. 1994. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 126:5-9.
30. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc. Natl. Acad. Sci. USA 90:4475-4479.
31. Hoffman, P., M. B. Yaffe, B. L. Hoffman, S. Yei, W. S. M. Wold, and C. Carlin. 1992. Characterization of the adenovirus E3 protein that down-regulates the epidermal growth factor receptor. Evidence for intermolecular disulfide bonding and plasma membrane localization. J. Biol. Chem. 267: 13480-13487.
32. 2. J. Biol. Chem. 267:39-42.
33. Horton, T. M., T. S. Ranheim, L. Aquino, D. I. Kusher, S. K. Saha, C. F. Ware, W.S.M. Wold, and L.R. Gooding. 1991. Adenovirus E3 14.7K protein functions in the absence of other adenovims proteins to protect transfected cells from tumor necrosis factor cytolysis. J. Virol. 65:2629-2639.
34. 2 in breast carcinoma cells. Oncogene 10:2297-2305.
35. Kenyon, D. J., J. Dougherty, and K. Raska, Jr. 1991. Tumorigenicity of adenovirus-transformed cells and their sensitivity to tumor necrosis factor α and NK/LAK cell cytolysis. Virology 180:818-821.
36. Kirstein, M., and C. Baglioni. 1986. Tumor necrosis factor induces synthesis of two proteins in human fibroblasts. J. Biol. Chem. 261:9565-9567.
37. Knauer, M. F., K. J. Longmuir, R. S. Yamamoto, T. P. Fitzgerald, and G. A. Granger. 1990. Mechanism of human lymphotoxin and tumor necrosis factor induced destruction of cells in vitro: phospholipase activation and deacylation of specific-membrane phospholipids. J. Cell. Physiol. 142:469-479.
38. Kolesnick, R., and D. W. Golde. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328.
39. Körner, H., U. Fritzsche, and H. G. Burgert. 1992. Tumor necrosis factor α stimulates expression of adenovirus early region 3 proteins: implications for viral persistence. Proc. Natl. Acad. Sci. USA 89:11857-11861.
40. Korzeniewski, C., and D. M. Callewaert. 1983. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods 64:313-320.
41. Krajcsi, P., T. Dimitrov, Y. Li, and W. S. M. Wold. 1995. Unpublished data.
42. cyt orientation. Virology 187:131-144.
43. Krajcsi, P., A. E. Tollefson, C. W. Anderson, and W. S. M. Wold. 1992. The adenovirus E3 14.5-kilodalton protein, which is required for down-regulation of the epidermal growth factor receptor and prevention of tumor necrosis factor cytolysis, is an integral membrane protein oriented with its C terminus in the cytoplasm. J. Virol. 66:1665-1673.
44. Kumar, S., and C. Baglioni. 1991. Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266:20960-20964.
45. Laster, S. M., J. G. Wood, and L. R. Gooding. 1988. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141: 2629-2634.
46. 2 in human fibroblasts. J. Biol. Chem. 267:23451-23454.
47. 2 is coupled to hormonally regulated release of arachidonic acid. Proc. Natl. Acad. Sci. USA 89:6147-6151.
48. 2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
49. Martin, S. J., and D. R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
50. Matthews, N., M. L. Neale, S. K. Jackson, and J. M. Stark. 1987. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62:153-155.
51. Mosmann, T. 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-64.
52. 2 by tumor necrosis factor α. Cancer Res. 52:866-872.
53. 2 activation in tumour cell killing by tumour necrosis factor. Immunology 64:81-35.
54. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268:1960-1964.
55. Opipari, A. W., Jr., H. M. Hu, R. Yabkowitz, and V. M. Dixit. 1992. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J. Biol. Chem. 267:12424-12427.
56. Ozaki, Y., T. Ohashi, and Y. Niwa. 1986. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem. Pharmacol. 35:3481-3488.
57. Palombella, V. J., and J. Vilcěk. 1989. Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. J. Biol. Chem. 264:18128-18136.
58. Peppelenbosch, M. P., R. G. Qiu, A. M. de Vries-Smits, L. G. Tertoolen, S. W. de Laat, F. McCormick, A. Hall, M. H. Symons, and J. L. Bos. 1995. Rac mediates growth factor-induced arachidonic acid release. Cell 81:849-856.
59. Prezioso, J. A., J. Wang, M. Kim, L. Duty, D. J. Tweardy, and E. Gorelik. 1995. Augmentation of TNF cytotoxicity by protein kinase C inhibitors: role of arachidonic acid and manganese Superoxide dismutase. Cytokine 7:517-525.
60. Ranheim, T. S, J. Shisler, T. M. Horton, L. J. Wold, L. R. Gooding, and W. S. M. Wold. 1993. Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor. J. Virol. 67:2159-2167.
61. Reid, T., C. S. Ramesha, and G. M. Ringold. 1991. Resistance to killing by tumor necrosis factor in an adipocyte cell line caused by a defect in arachidonic acid biosynthesis. J. Biol. Chem. 266:16580-16586.
62. Reid, T. R., F. M. Torti, and G. M. Ringold. 1989. Evidence for two mechanisms by which tumor necrosis factor kills cells. J. Biol. Chem. 264:4583-4589.
63. Rizzo, M. T., H. S. Boswell, L. Mangoni, C. Carlo-Stella, and V. Rizzoli. 1995. Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-α: evidence for a tyrosine-kinase-dependent process. Blood 86:2967-2975.
64. Shisler, J., P. Duerksen-Hughes, T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. Induction of susceptibility to tumor necrosis factor by adenovirus E1A is dependent on binding 10 either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70:68-77.
65. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region E3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70:2431-2439.
66. Stewart, A. R., A. E. Tollefson, P. Krajcsi, S. P. Yei, and W. S. M. Wold, 1995 The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane. J. Virol. 69:172-181.
67. Subramanian, T., J. M. Boyd, and G. Chinnadurai. 1995. Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins. Oncogene 11:2403-2409.
68. 2 activity, but not with araehidonic acid release per se. Eur. J. Biochem. 195:465-475.
69. Tollefson, A. E., P. Krajcsi, M. H. Pursley, L. R. Gooding, and W. S. M. Wold. 1990. A 14,500 MW protein is coded by region E3 of group C human adenoviruses. Virology 175:19-29.
70. Tollefson, A. E., P. Krajcsi, S. P. Yei, C. R. Carlin, and W. S. M. Wold. 1990. A 10,400-molecular-weight membrane protein is coded by region E3 of adenovirus. J. Virol. 64:794-801.
71. Tollefson, A. E., A. R. Stewart, S. P. Yei, S. K. Saha, and W. S. M. Wold. 1991. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. J. Virol. 65:3095-3105.
72. Tollefson, A. E., and W. S. M. Wold. 1995. Unpublished data.
73. Tracey, K. J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-343.
74. Tsuji, Y., J. Ninomiya-Tsuji, S. V. Torti, and F. M. Torti. 1993. Augmentation by IL-1α of tumor necrosis factor-α cytotoxicity in cells transfecied with adenovirus E1A. J. Immunol. 150:1897-1907.
75. Tufariello, J., S. Cho, and M. S. Horwitz. 1994. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J. Virol. 68:453-462.
76. Tufariello, J. M., S. Cho, and M. S. Horwitz. 1994. Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. USA 91:10987-10991.
77. Vande Pol, S. B., and P. M. Howley. 1992. The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latency. J. Virol. 66:2346-2358.
78. Vanhaesebroeck, B., H. T. Timmers, G. J. Pronk, F. van Roy, A. J. Van der Eb, and W. Fiers. 1990. Modulation of cellular susceptibility to the cytotoxic/cytostatic action of tumor necrosis factor by adenovirus El gene expression is cell type-dependent. Virology 176:362-368.
79. Voelkel-Johnson, C., A. J. Entingh, W. S. M. Wold, L. R. Gooding, and S. M. Laster. 1995. Activation of intracellular proteases is an early event in TNF-indueed apoptosis. J Immunol. 154:1707-1716.
80. 2 in human melanoma tumor cells. J. Immunol. 156:201-207.
81. White, E., S. H. Blose, and B. W. Stillman. 1984. Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA. Mol. Cell. Biol. 4:2865-2875.
82. White, E., P. Sabbatini, M. Debbas, W. S. M. Wold, D. I. Kusher, and L. R. Gooding. 1992. The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol. 12:2570-2580.
83. Wold, W. S. M. 1943. Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF. J. Cell. Biochem. 53:329-335.
84. Wold, W. S. M., and L. R. Gooding. 1989. Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. Mol. Biol. Med. 6:433-452.
85. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1-8.
86. Wold, W. S. M., T. W. Hermiston, and A. E. Tollefson. 1994. Adenovirus proteins that subvert host defenses. Trends Microbiol. 2:437-443.
87. Wold, W. S. M., A. E. Tollefson, and T. W. Hermiston. 1995. E3 transcription unit of adenovirus, p. 237-274. In W. Doerfler and P. Bohm (ed.), The molecular repertoire of adenoviruses. Springer-Verlag, Heidelberg.
88. Wong, G. H., J. H. Elwell, L. W. Oberley, and D. V. Goeddel. 1989. Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931.
89. Wong, H. H., and D. V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature (London) 323:819-822.
90. Yang, Y. C., B. A. Spalholz, M. S. Rabson, and P. M. Howley. 1985. Dissociation of transforming and transactivation functions for bovine papillomavirus type I. Nature (London) 318:575-577.
91. Zilli, D., C. Voelkel-Johnson, T. Skinner, and S. M. Laster. 1992. The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Bioehem. Biophy. Res. Commun. 188:177-183.